| Recent Developments in the Treatment of Bladder Cancer | p. 3 |
| Interferon-[alpha] Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines | p. 15 |
| Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma | p. 33 |
| Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomakers | p. 47 |
| The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder | p. 61 |
| Prediction of Lymph Node Metastasis Based on P53 and nm23-H1 Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder | p. 67 |
| Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer | p. 87 |
| Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence? | p. 99 |
| Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer | p. 111 |
| The Effect of Contrast Material on Transitional Cell Carcinoma Viability | p. 121 |
| Flurodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma | p. 129 |
| Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder | p. 143 |
| Gene and Antisense Therapy of Bladder Cancer | p. 155 |
| Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapy | p. 185 |
| Molecular Response of the Bladder to Obstruction | p. 195 |
| The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Obstruction | p. 217 |
| Intercellular Communication and Bladder Function | p. 239 |
| Ischemia as an Etiological Factor in Bladder Instability: Implications for Therapy | p. 255 |
| Effect of Chronic Ischemia on Bladder Structure and Function | p. 271 |
| Ultrastructural Diagnosis of Neuropathic Detrusor Overactivity: Validation of a Common Myogenic Mechanism | p. 281 |
| Serial Changes of Smooth Muscle Cell Phenotypes in Rat Urinary Bladder Following Partial Outflow Obstruction | p. 293 |
| Study of Detrusor Dysfunction Due to Outlet Obstruction: Link Between Analysis of Uroflows of Men with Benign Prostatic Hyperplasia and Animal Studies | p. 297 |
| Ultrasonic Measurement of Bladder Weight as a Novel Urodynamic Modality | p. 311 |
| Experimental Neurogenic Cystitis | p. 319 |
| Murine In Vitro Whole Bladder Physiology | p. 337 |
| Ca[superscript 2+] Sparks and K[subscript Ca] Channels: Novel Mechanisms to Relax Urinary Bladder Smooth Muscle | p. 347 |
| The Effect of Intravesical Capsaicin and Resiniferatoxin in Neurogenic Bladder Dysfunction | p. 359 |
| On the Physioanatomy of Micturition and Urinary Continence - New Concepts | p. 381 |
| Stress Urinary Incontinence: New Concept of Pathogenesis and Treatment by Pudendal Canal Decompression | p. 415 |
| Transcutaneous Electrovesicogram in Normal Volunteers and Patients with Interstitial Cystitis, Neurogenic Bladder, Benign Prostatic Hyperplasia, and after Cystectomy | p. 441 |
| Extracorporeal Electromagnetic Stimulation for Urinary Incontinence and Bladder Disease | p. 453 |
| Pubovaginal Sling Surgery without Using Abdominal Leak Point Pressure: An Outcomes Analysis | p. 467 |
| The Use of Synthetic Materials in Pubovaginal Sling | p. 481 |
| Surgical Implantation of the Synthetic Sling (The 6-Point Fixation Technique and Weight-Adjusted Spacing Nomogram): Technique and Results | p. 493 |
| Reconstructive Surgery in Neuropathic Bladder | p. 509 |
| The Role of the Simple Cystectomy in Urologic Surgery | p. 535 |
| Neurogenic Inflammation of the Bladder | p. 551 |
| Urine-Induced Apptosis in Cultured Bladder Urothelial Cells | p. 585 |
| Bacillus of Calmette and Guerin Modulates Nuclear Factor Kappa [beta] in Two Urothelial Carcinoma Cell Lines | p. 599 |
| Induction of Urothelial Cell Proliferation by Fibroblast Growth Factor-7 in RAGI-Deficient Mice | p. 623 |
| Development of a Recombinant FimCH Vaccine for Urinary Tract Infections | p. 635 |
| Intravesicular Pain Mapping | p. 655 |
| A Hypothesis for the Etiology of Interstitial Cystitis | p. 683 |
| Pentosanpolysulfate (Elmiron) is a Potent Inhibitor of Mast Cell Histamine Secretion | p. 713 |
| The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0.2% in Potassium Tested Positive Patients with Interstitial Cystitis | p. 731 |
| Cystectomy Causes Immunosuppression in Bladder Cancer | p. 741 |
| Nocturia | p. 751 |
| The Fate of Urinary Bladder Smooth Muscle after Outlet Obstruction - A Role for the Sarcoplasmic Reticulum | p. 773 |
| Alteration of Collagen Three-Dimensional Architecture in Noncompliant Human Urinary Bladder | p. 791 |
| Modulation of Angiogenesis: Experimental Strategies and Potential Therapeutic Applications | p. 803 |
| Methods of Testing Urethral Resistance in the Female Rat | p. 831 |
| Virtual Reality Surgical Simulation for Lower Urinary Tract Endourologic Surgery | p. 841 |
| Autologous Muscle Transfer for Reconstruction of the Lower Urinary Tract | p. 853 |
| Effectiveness of Denuding the Intestinal Mucosa by Submucosal Injection in the Porcine Model | p. 869 |
| Urinary Diversion in the Management of Chronic Perineal Skin Ulceration in Spinal Cord Injured Patients Following Sphincterotomy | p. 879 |
| The Artificial Urinary Bladder | p. 885 |
| Comparison of the Breaking Strength of Polyglactin Mesh in Urine, Serum, and Cell Culture Media | p. 895 |
| Growth of Cultured Human Urothelial Cells Into Stratified Urothelial Sheet Suitable for Autografts | p. 907 |
| Future Perspectives in Bladder Reconstruction | p. 921 |
| Subject Index | p. 941 |
| Table of Contents provided by Blackwell. All Rights Reserved. |